Score Breakdown
Below average.
Intel is executing a high-stakes manufacturing turnaround that is technologically promising (18A gate-all-around, backside power) but financially punishing. The Foundry business burns $10B+ annually, FCF has been deeply negative for two years, and the share count is being massively diluted through government warrants (433M shares + 241M warrants) and strategic placements (215M shares to Nvidia). At ~$48/share and ~$240B market cap, the stock prices in significant turnaround success despite 60% 18A yields (vs TSMC's 70-80% at 2nm), no meaningful external foundry revenue until 2027+, and a forward P/E of ~56x. The balance sheet is stabilized at $37B cash thanks to emergency-style capital raises, but this came at enormous dilution cost. While management is competent and the strategic assets are real (CHIPS Act grants, Mobileye, x86 installed base), the risk/reward at current prices skews negative given the execution gauntlet ahead and the 12%+ annual dilution.
Negative cash flow. Can't value it.
Major red flags in SEC filings.
Slow bleed.
No data.
Plenty of cash.
Bears aren't interested.
Decent.
🐻 Why Bears Hate It
Bears argue that Intel's turnaround is a 'show me' story with high execution risk. The company suffered consistent losses prior to Q3 2025 and is currently trading at a high valuation (forward P/E ~56x) following a speculative 85% rally. Critics point to 18A yield rates of ~60%, which, while improving, still lag significantly behind TSMC’s 70-80% yields for its 2nm process (Sources: Substack/Vinh, Nasdaq).
🔍 What's In The SEC Filings
Intel is aggressively utilizing complex off-balance-sheet co-investment structures and dilutive private placements to fund massive foundry losses, while facing significant litigation and regulatory accounting challenges.
Direct SEC objection to government grant accounting treatment.
“In December 2025, the staff completed its review of our accounting position and informed us that they objected to a component of our accounting treatment. Specifically, the SEC objected to our position that receipts from the U.S. government under the Secure Enclave program... should be accounted for as a government grant.”
Management attempted to recognize $3.0 billion as grant income (which would offset expenses/COGS) instead of equity, which artificially bolsters operating metrics at the expense of shareholder dilution.
Derivative liabilities stemming from construction delays in Ireland.
“In 2024 we recognized a loss of $755 million within interest and other, net from the change in fair value of the liquidated damage provisions, which qualify as a non-designated derivative.”
Complex 'Semiconductor Co-Investment Program' (SCIP) agreements contain liquidated damage clauses up to $1.1 billion if construction milestones are missed, creating volatile non-cash losses that signal execution failure.
Massive issuance of common stock and warrants to competitors and government.
“The company agreed to issue to the DOC: (i) up to 433 million shares of our common stock... and (ii) warrants exercisable to purchase up to 241 million shares... we entered into an agreement to issue and sell 215 million shares of our common stock to NVIDIA.”
Intel is raising billions in emergency-style capital from the U.S. government and competitors (NVIDIA), significantly diluting existing shareholders to maintain liquidity for its capital-intensive foundry strategy.
Massive operating losses in the Foundry segment obscured by segment reshuffling.
“Intel Foundry... Operating income (loss) $(10,318) [million].”
Integrating the 'NEX' business into other segments and shifting to a 'foundry model' allows management to redistribute costs and hide the true magnitude of the $10 billion annual loss in the manufacturing arm.
Substantial unpaid litigation awards with uncertain total exposure.
“As of December 27, 2025, we have accrued liabilities of $1.0 billion related to litigation involving VLSI... we are unable to make a reasonable estimate of losses in excess of recorded amounts.”
Jury awards in Texas (VLSI) have reached as high as $2.2 billion and $949 million; if appeals fail, cash outflows could significantly exceed current accruals.
Intrinsic value is severely impaired by the 'Warrant Condition' and Escrowed Shares which effectively cap the upside for common shareholders if the Foundry business is spun off or fails. The $10B+ annual operating loss in Foundry necessitates a massive valuation discount compared to fabless peers.
Management tone is heavily reliant on 'restructuring' and 'organizational change' to explain financial volatility. The divestiture of Altera and partial sale of Mobileye shares suggests a 'fire sale' mentality to fund the Foundry's cash burn.